Comparative Effectiveness Research (CER), as defined by the United States Department of Health and Human Services, is the conduct and synthesis of systematic research comparing different interventions and strategies to prevent, diagnose, treat, and monitor health conditions. The purpose of this research is to inform patients, providers, and decision-makers, responding to their expressed needs, about which interventions are most effective for which patients under specific circumstances. To provide this information, comparative effectiveness research must assess a comprehensive array of health-related outcomes for diverse patient populations. Defined interventions compared may include medications, procedures, medical and assistive devices and technologies, behavioral change strategies, and delivery system interventions. This research necessitates the development, expansion, and use of a variety of data sources and methods to assess comparative effectiveness.
For the last several years, Friends of Cancer Research (Friends) has been a thought leader in CER and its advancement in the cancer field. Numerous studies exploring the efficacy and implementation of CER in oncology are available below.
The Patient-Centered Outcomes Research Institute (PCORI), established under the Patient Protection and Affordable Care Act of 2010, is a non-profit, independent organization comprised of a board of governors with 21 members chosen from areas of industry, government, and advocacy. Ellen Sigal, Chairperson and founder of Friends, serves as one of the founding members of this board. PCORI is headed by the director of the Agency for Healthcare Research and Quality (AHRQ) and the director of the National Institutes of Health (NIH) or their designees. Nineteen members of the board of governors are appointed to 2, 4, and 6 year terms, respectively. PCORI also consists of a 17 member methodology committee focused on advancing the science and methodology of comparative effectiveness research.
PCORI's mission is to provide doctors and patients with science driven data to support the best prevention, treatment, and care options available to individual patients. While the research produced by PCORI is meant to inform stakeholders, no suggestions made by the board can be or should be construed as mandates for care.
You can learn more about PCORI at http://www.pcori.org/
FRIENDS OF CANCER RESEARCH
1800 M Street NW Suite 1050 | Washington, DC 20036